wound care today
Choosing the right treatment can be frustrating for medical practitioners as most wound care systems in the market are not designed to address the complexities of different wound types.
Rapid Nexus simplifies the wound treatment with Hemastyl Rx® Wound dressing, a nanoparticle formulation that treats wounds of all types, including severe ones that have previously been non-responsive to standard products and treatment.
Compared with existing chronic wound treatments, patients with co-morbidities treated with Hemastyl Rx® Wound dressing formulation enjoy a more effective treatment, reducing hospitalizations which often lead to amputations.
How Rapid Nexus wound healing system works
A simplified approach
Rapid Nexus simplifies local wound care with a wound healing system that addresses the complicated needs of wound patients. Hemastyl-R® is a self-debriding dressing that maintains a proper moist wound healing environment, controls bacterial bioburden within the gel wound dressing and contains hyaluronic acid which donates moisture to the cells, connects fibrin to build skin matrix effectively.
Hemastyl-R® Wound dressing formulation is a breakthrough technology that effectively manages severe wounds and diminishes the need for additional surgical intervention for some patients. We have simplified the treatment method to help physicians aid more patients and save more lives in the process.
Our Rapid Nexus home kits are designed to allow doctors to treat patients via telemedicine.
Why Hemastyl-R® Wound dressing formulation is best for your patient
Examples of severe lower extremity non-healing chronic wounds before and after treatment with the Hemastyl Rx® with the Hemastyl-R® Wound gel dressing composition. The wounds include vascular and diabetic ulcers with severe peripheral blood circulation dysfunction and/or severe necrosis.
- Acute wounds
- Chronic wounds